This page in Swedish

Lovisa Bergengren

Position: Affiliated Researcher School/office: School of Medical Sciences

Email: bG92aXNhLmJlcmdlbmdyZW47b3J1LnNl

Phone: No number available

Room: -

Research subject

Surgical Science

About Lovisa Bergengren

Lovisa Bergengren works as a senior consultant at the department of Women's health at Örebro University Hospital, with a specialization in obstetrics and gynaecolgy. She is responsible for the cervical screening programme in the Region of Örebro County; is the process leader of cervical screening in RCC Uppsala Örebro and represents the region in the national working group for prevention of cervical cancer, NACx; and is a memeber of the Swedish National Cervical Screening Registry steering committee.

Research

PhD from Örebro University 2020 "Cervical screening with primary HPV - from research to clinical effectiveness". Research area is strategies for HPV screening to identify women at highest risk for cervical cancer.

Active projects

Research groups

Publications

Articles in journals | Conference papers | Doctoral theses, comprehensive summaries | Manuscripts |

Articles in journals

Jans, L. , Brynhildsen, J. , Cherif, E. , Tenerz, L. & Bergengren, L. (2024). Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study. European journal of contraception & reproductive health care, 29 (3), 109-114. [BibTeX]
Helenius, G. , Lillsunde-Larsson, G. & Bergengren, L. (2023). Molecular triage of cervical screening samples in women 55-59 years of age: a pilot study. Infectious Agents and Cancer, 18 (1). [BibTeX]
Bergengren, L. , Ryen, L. , Flodström, C. , Fadl, H. , Udumyen, R. , Karlsson, M. G. & Helenius, G. (2022). Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden: A population based cohort study. Preventive Medicine Reports, 25. [BibTeX]
Kaliff, M. , Lillsunde-Larsson, G. , Helenius, G. , Karlsson, M. & Bergengren, L. (2022). Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden. PLOS ONE, 17 (9). [BibTeX]
Jans, L. , Zetterström, K. , Bergengren, L. & Helenius, G. (2021). The value of adding a single co-test in HPV primary screening. Preventive Medicine, 149. [BibTeX]
Bergengren, L. , Karlsson, M. & Helenius, G. (2020). Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the Swedish cervical cancer screening program. Cancer Causes and Control, 31 (4), 377-381. [BibTeX]
Bergengren, L. , Lillsunde-Larsson, G. , Helenius, G. & Karlsson, M. G. (2019). HPV-based screening for cervical cancer among women 55-59 years of age. PLOS ONE, 14 (6). [BibTeX]
Bergengren, L. , Kaliff, M. , Lillsunde-Larsson, G. , Karlsson, M. & Helenius, G. (2018). Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women. International Journal of Gynecology & Obstetrics, 142 (3), 359-364. [BibTeX]
Lillsunde Larsson, G. , Kaliff, M. , Bergengren, L. , Karlsson, M. G. & Helenius, G. (2016). HPV Genotyping from the high risk mRNA Aptima assay: a direct approach using DNA from Aptima sample tubes. Journal of Virological Methods, 235, 80-84. [BibTeX]

Conference papers

Bergengren, L. (2023). Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk humanpapillomavirus-positive samples from women over 30 years participating in cervical cancerscreening in Örebro, Sweden. In: Shaped Challenges of HPV Driven Cancers From Research to Practice. Paper presented at EUROGIN 2023, Bilbao, Portugal, February 8-11, 2023. [BibTeX]
Kaliff, M. , Bergengren, L. , Helenius, G. , Karlsson, M. & Lillsunde-Larsson, G. (2019). DNA methylation analysis in HPV-positive screening samples from women 30-69 years in the cervical cancer-screening program in Örebro, Sweden: a pilot study. In: EUROGIN 2019 ABSTRACTS POSTERS. Paper presented at EUROGIN 2019: International Multidisciplinary HPV Congress, Monaco, December 4-7, 2019. [BibTeX]
Helenius, G. , Lillsunde-Larsson, G. , Bergengren, L. , Kaliff, M. & Karlsson, M. (2019). Preliminary data from a Swedish self-sampling study in postmenopausal women. Paper presented at EUROGIN 2019 – International Multidisciplinary HPV Congress, Monte Carlo, Monaco, December 4-7, 2019. [BibTeX]
Helenius, G. , Ottestig, E. , Kaliff, M. , Lillsunde-Larsson, G. , Karlsson, M. & Bergengren, L. (2018). Distribution of HPV-genotypes in a Swedish screening population. Paper presented at Eurogin 2018 International multidisciplinary HPV Congress, Lisabon Portugal, December 2-5, 2018. [BibTeX]
Bergengren, L. (2017). HPV INFECTION AMONG ELDERLY WOMEN: a population based cohort study. Paper presented at Eurogin, Amsterdam, the Netherlands, 2017. [BibTeX]
Bergengren, L. , Lillsunde-Larsson, G. , Kaliff, M. , Karlsson, M. & Helenius, G. (2016). Concordance between self sampling and professionally taken cervical hpv test-result from population based cohort study. Paper presented at Eurogin, Salzburg, Austria, 2016. [BibTeX]
Bergengren, L. (2015). Prevalence of HPV low and high risk genotypes in older women in Sweden: first results from a population based cohort study. Paper presented at Eurogin, Lissabon, Portugal, 2015. [BibTeX]

Doctoral theses, comprehensive summaries

Bergengren, L. (2020). Cervical screening with primary HPV: from research to clinical effectiveness. (Doctoral dissertation). (Comprehensive summary) Örebro: Örebro University. [BibTeX]

Manuscripts

Bergengren, L. , Ryen, L. , Flodström, C. , Fadl, H. , Udumyan, R. , Karlsson, M. & Helenius, G. Effectiveness and costs of implemented primary HPV cervical screening : a populationbased cohort study. [BibTeX]
Kaliff, M. , Ekman, M. , Ottestig, E. , Helenius, G. , Bergengren, L. , Karlsson, M. G. & Lillsunde-Larsson, G. Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk HPV-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden. [BibTeX]